Risk of thromboembolism after cerebral venous thrombosis

European Journal of Neurology

Volumn 13, Issue 3, 2006, Pages 302-305

  Maqueda, V M ^a   Thijs, V ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Department of Neurology ^*  (Belgium)

Author keywords

Cerebral venous thrombosis; Stroke

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN VEIN; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; TELEPHONE; THROMBOEMBOLISM; UNIVERSITY HOSPITAL; VEIN THROMBOSIS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33645310646     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01211.x     Document Type: Article

References (8)

1. Bousser MG. Cerebral venous thrombosis: diagnosis and management. Journal of Neurology 2000 247 252 258.
2. Ferro JM Canhao P Stam J Bousser MG Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004 35 664 670.
3. Preter M Tzourio C Ameri A Bousser MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 1996 27 243 246.
4. Breteau G Mounier-Vehier F Godefroy O et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. Journal of Neurology 2003 250 29 35.
5. Buller HR Agnelli G Hull RD Hyers TM Prins MH Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 (Suppl. 401S 428S.
6. Baglin T Luddington R Brown K Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003 362 523 526.
7. Kearon C Ginsberg JS Kovacs MJ et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. New England Journal of Medicine 2003 349 631 639.
8. Ridker PM Goldhaber SZ Danielson E et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine 2003 348 1425 1434.